Cutaneous follicle center lymphoma, spleen is a rare type of non-Hodgkin lymphoma characterized by the proliferation of B-cells in the skin and spleen. This condition can lead to significant morbidity due to its potential for local and systemic spread. Accurate coding with ICD-10 Code C82.67 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.
ICD-10 Code C82.67 specifically denotes Cutaneous follicle center lymphoma localized to the spleen. This condition arises from malignant transformation of follicle center B-cells, often presenting with skin lesions and splenic involvement. The code should be utilized in clinical documentation and billing when a patient is diagnosed with this specific lymphoma type, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Cutaneous follicle center lymphoma, spleen is a subtype of B-cell lymphoma that primarily affects the skin and spleen. The etiology is linked to genetic mutations and environmental factors, leading to abnormal proliferation of B-cells. Early recognition and treatment are crucial to prevent progression and complications.
ICD-10 Code C82.67 is utilized in SOAP notes to document the diagnosis of Cutaneous follicle center lymphoma affecting the spleen. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C82.67 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Cutaneous follicle center lymphoma, spleen. This coding ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Cutaneous follicle center lymphoma, spleen requires a multidisciplinary approach, often necessitating hospitalization for severe cases. Treatment may include chemotherapy, radiation, or targeted therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.67 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description | 
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. | 
| 85025 | Complete blood count with automated differential. | 
| 88305 | Pathology examination of tissue, including biopsy. | 
| 99214 | Established patient office visit, moderate complexity. | 
Common Questions About Using ICD-10 Code C82.67 for Cutaneous follicle center lymphoma, spleen
What are the common symptoms of Cutaneous follicle center lymphoma, spleen?
Common symptoms include skin lesions, splenomegaly, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and itching.
How is Cutaneous follicle center lymphoma, spleen diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of skin lesions to confirm the presence of follicle center lymphoma.
What treatment options are available for this condition?
Treatment may include chemotherapy, radiation therapy, and targeted therapies. Supportive care is also important to manage symptoms and improve quality of life.
Is Cutaneous follicle center lymphoma, spleen contagious?
No, Cutaneous follicle center lymphoma is not contagious. It is a malignancy arising from B-cells and does not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes